1-7 of 7
Elena Beatriz Moiraghi, MD
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

"M3-M6" Molecular Response Evolution As Early Predictor of Outcome Considering Generic Vs Branded TKIs for Chronic Myeloid Leukemia (CML): An Argentine Multicentric Study

Isabel Amanda Giere, PhD M.Sc, María Jose Mela Osorio, MD, Federico Andrés Klosowski, Mariana Debus, Federico Sackmann, MD, Miguel A Pavlovsky, MD, Isolda Fernandez, MD, Elena Beatriz Moiraghi, MD, Ana Inés Varela, MD, Mariel Ana Perez, MD, Julio M. Pose Cabarcos, MD, Georgina Bendek, MD, Romina Mariano, MD, Silvina Palmer, MD, Alicia Enrico, MD, Isabel Cristina Annetta, MD, Andres L. Brodsky, MD PhD, Dante Intile, Statistic MD, Carolina Pavlovsky, MD
Journal: Blood
Blood (2016) 128 (22): 5445.
https://doi.org/10.1182/blood.V128.22.5445.5445
Published: 2016
Journal Articles

Patient-Reported Quality of Life before and after Stopping Treatment in the ENESTop Trial of Treatment-Free Remission for Patients with Chronic Myeloid Leukemia in Chronic Phase

François-Xavier Mahon, MD PhD, Carla Maria Boquimpani, Naoto Takahashi, MD PhD, Noam Benyamini, MD, Nelma Cristina D Clementino, MD, Vasily Shuvaev, MD, Sikander Ailawadhi, MD, Jeffrey H. Lipton, MD PhD, Anna G Turkina, Prof., MD, Elena Beatriz Moiraghi, MD, Franck-Emmanuel Nicolini, MD PhD, Jolanta Dengler, Tomasz Sacha, Dong-Wook Kim, MD PhD, Rafik Fellague-Chebra, MD MSc, Sandip Acharya, MSc, Patricia Brandt, Ari Gnanasakthy, MBA, MSc, Yu Jin, MS, Timothy P. Hughes, MD FRACP, FRCPA, MBBS, FAAHMS
Journal: Blood
Blood (2016) 128 (22): 1891.
https://doi.org/10.1182/blood.V128.22.1891.1891
Published: 2016
Journal Articles

Treatment-Free Remission in Patients with Chronic Myeloid Leukemia in Chronic Phase According to Reasons for Switching from Imatinib to Nilotinib: Subgroup Analysis from ENESTop

Timothy P. Hughes, MD FRACP, FRCPA, MBBS, FAAHMS, Carla Maria Boquimpani, Naoto Takahashi, MD PhD, Noam Benyamini, MD, Nelma Cristina D Clementino, MD, Vasily Shuvaev, MD, Sikander Ailawadhi, MD, Jeffrey H. Lipton, MD PhD, Anna G Turkina, Prof., MD, Elena Beatriz Moiraghi, MD, Franck E. Nicolini, MD PhD, Jolanta Dengler, Tomasz Sacha, Dong-Wook Kim, MD PhD, Rafik Fellague-Chebra, MD MSc, Sandip Acharya, MSc, Nancy Krunic, PhD, Yu Jin, MS, François-Xavier Mahon, MD PhD
Journal: Blood
Blood (2016) 128 (22): 792.
https://doi.org/10.1182/blood.V128.22.792.792
Published: 2016
Journal Articles

Chronic Myeloid Leukemia (CML): BCR-ABL Transcript Levels Halving Time and Relative Reduction Ratio at Months 3 As New Predictors of Outcome. an Argentine Pilot Study

Isabel Amanda Giere, PhD M.Sc, María Jose Mela Osorio, MD, Federico Andrés Klosowski, Mariana Debus, Ana Inés Varela, MD, Elena Beatriz Moiraghi, MD, Miguel A Pavlovsky, MD, Isolda Fernandez, MD, Dante Intile, Statistic, Carolina Pavlovsky, MD
Journal: Blood
Blood (2015) 126 (23): 1590.
https://doi.org/10.1182/blood.V126.23.1590.1590
Published: 2015
Journal Articles

Exploring the Significance of TP53, ABCB1 and GST Polymorphisms on Susceptibility and Pharmacogenetics in Argentinian Patients with Chronic Myeloid Leukemia

Natalia Weich, Master in Science, Cristian Ferri, PhD, Elena Beatriz Moiraghi, MD, Raquel Maria Nelida Bengio, MD, Isabel Amanda Giere, PhD M.Sc, Carolina Pavlovsky, MD, Irene Larripa, PhD, Ariela Freya Fundia, PhD
Journal: Blood
Blood (2015) 126 (23): 5134.
https://doi.org/10.1182/blood.V126.23.5134.5134
Published: 2015
Journal Articles

Daily Practice Experience in Ponatinib Treatment of Chronic Myeloid Leukemia (CML) Patients Resistant to Other Tyrosin Kynase Inhibitors (TKIs) in Argentina

Ana Inés Varela, MD, Romina Laura Penalba, Alicia Enrico, MD, Marta Catalan, Maria Veronica Ventriglia, Maria Josefina Freitas, Carolina Pavlovsky, MD, Susana Garbiero, PhD, Martin Beccasese, MD, Raquel Maria Nelida Bengio, MD, Catalina Abramovich, MD, Miguel A Pavlovsky, MD, Elena Beatriz Moiraghi, MD
Journal: Blood
Blood (2015) 126 (23): 5149.
https://doi.org/10.1182/blood.V126.23.5149.5149
Published: 2015
Journal Articles

Adherence to Imatinib Mesylate Treatment: Two Years Follow up

Carlos A. Doti, M.D., German R Stemmelin, M.D., Elena Beatriz Moiraghi, MD, María Gabriela Flores, MD, Juan Garcia, MD, Hector Murro, MD, Eduardo O Bullorsky
Journal: Blood
Blood (2008) 112 (11): 4267.
https://doi.org/10.1182/blood.V112.11.4267.4267
Published: 2008